aurintricarboxylic acid has been researched along with ellagic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Babaoglu, K; Cancian, L; Costi, MP; Feng, B; Inglese, J; Irwin, JJ; Jadhav, A; Maltby, DA; Nelson, ME; Shoichet, BK; Simeonov, A; Thomas, CJ | 1 |
| Hadden, MK; Korzhnev, DM | 1 |
| Adriaenssens, Y; Augustyns, K; Cleenewerck, M; De Meyer, GRY; Declercq, W; Gladysz, R; Grootaert, MOJ; Joossens, J; Lambeir, AM; Martinet, W; Roelandt, R; Van der Veken, P | 1 |
| Bilbao, A; Bujons, J; Comas-Barceló, J; Quintana, M; Triola, G | 1 |
| Cho, YW; Han, MH; Han, S; Kim, BC; Lim, HJ | 1 |
| Barnea, A; Chapman, S; David, AB; Diamant, E; Dor, E; Epstein, E; Levin, L; Mimran, LC; Natan, N; Torgeman, A; Zichel, R | 1 |
1 review(s) available for aurintricarboxylic acid and ellagic acid
| Article | Year |
|---|---|
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Cell Survival; DNA Damage; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neoplasms; Small Molecule Libraries; Structure-Activity Relationship | 2016 |
5 other study(ies) available for aurintricarboxylic acid and ellagic acid
| Article | Year |
|---|---|
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase.
Topics: beta-Lactamase Inhibitors; Crystallography; Drug Evaluation, Preclinical; Enzyme Inhibitors; Mass Spectrometry; Structure-Activity Relationship | 2008 |
Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.
Topics: Autophagy; Autophagy-Related Proteins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Evaluation, Preclinical; Electrophoresis; Enzyme Assays; Humans; Temperature | 2016 |
Identification of benzo[cd]indol-2(1H)-ones as novel Atg4B inhibitors via a structure-based virtual screening and a novel AlphaScreen assay.
Topics: Autophagy-Related Proteins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Lactams; Models, Molecular; Molecular Structure; Naphthalenes; Structure-Activity Relationship | 2019 |
Small molecule inhibitors of IκB kinase β: A chip-based screening and molecular docking simulation.
Topics: Drug Evaluation, Preclinical; Humans; I-kappa B Kinase; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Small Molecule Libraries; Structure-Activity Relationship; Thermodynamics | 2020 |
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Aurintricarboxylic Acid; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Ellagic Acid; Heparin; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Protein Domains; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Internalization | 2021 |